ID   ST2A6_RAT               Reviewed;         284 AA.
AC   P22789; Q63551;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   27-MAR-2024, entry version 153.
DE   RecName: Full=Sulfotransferase 2A6 {ECO:0000305};
DE            Short=ST2A6;
DE            EC=2.8.2.2 {ECO:0000269|PubMed:2754334};
DE   AltName: Full=Androsterone-sulfating sulfotransferase {ECO:0000303|PubMed:8352748};
DE            Short=AD-ST {ECO:0000303|PubMed:8352748};
DE   AltName: Full=Bile acid:3'phosphoadenosine-5'phosphosulfate:sulfotransferase I {ECO:0000303|PubMed:2754334};
DE            Short=BAST I {ECO:0000303|PubMed:2754334};
DE            EC=2.8.2.14 {ECO:0000269|PubMed:2754334};
DE   AltName: Full=Hydroxysteroid sulfotransferase A {ECO:0000303|PubMed:2306259};
DE            Short=STa {ECO:0000303|PubMed:2306259, ECO:0000303|PubMed:8033248};
DE   AltName: Full=ST-40 {ECO:0000303|PubMed:8033248};
DE   AltName: Full=ST-41 {ECO:0000303|PubMed:8033248};
DE   AltName: Full=Senescence marker protein 2A {ECO:0000303|PubMed:2302387};
GN   Name=Sult2a6 {ECO:0000312|RGD:3727}; Synonyms=Smp2a, St2a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 174-184 AND 234-239.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2306259; DOI=10.1016/0006-291x(90)91036-r;
RA   Ogura K., Kajita J., Narihata H., Watabe T., Ozawa S., Nagata K.,
RA   Yamazoe Y., Kato R.;
RT   "cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong
RT   homology in amino acid sequence with the senescence marker protein SMP-2 in
RT   rat livers.";
RL   Biochem. Biophys. Res. Commun. 166:1494-1500(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8033248; DOI=10.1016/0009-2797(94)90059-0;
RA   Ogura K., Satsukawa M., Okuda H., Hiratsuka A., Watabe T.;
RT   "Major hydroxysteroid sulfotransferase STa in rat liver cytosol may consist
RT   of two microheterogeneous subunits.";
RL   Chem. Biol. Interact. 92:129-144(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-115.
RX   PubMed=2302387; DOI=10.1021/bi00454a031;
RA   Song C.S., Kim J.M., Roy A.K., Chatterjee B.;
RT   "Structure and regulation of the senescence marker protein 2 gene
RT   promoter.";
RL   Biochemistry 29:542-551(1990).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-37, IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=2754334;
RA   Barnes S., Buchina E.S., King R.J., McBurnett T., Taylor K.B.;
RT   "Bile acid sulfotransferase I from rat liver sulfates bile acids and 3-
RT   hydroxy steroids: purification, N-terminal amino acid sequence, and kinetic
RT   properties.";
RL   J. Lipid Res. 30:529-540(1989).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-46, SUBUNIT, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY,
RP   AND INDUCTION.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8352748; DOI=10.1042/bj2930795;
RA   Takahashi M., Homma H., Matsui M.;
RT   "Developmental changes in the isoelectric variants of rat hepatic
RT   hydroxysteroid sulphotransferase.";
RL   Biochem. J. 293:795-800(1993).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-21.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2113604;
RA   Ogura K., Sohtome T., Sugiyama A., Okuda H., Hiratsuka A., Watabe T.;
RT   "Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a)
RT   catalyzing the formation of reactive sulfate esters from carcinogenic
RT   polycyclic hydroxymethylarenes.";
RL   Mol. Pharmacol. 37:848-854(1990).
CC   -!- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate
CC       (PAPS) as sulfonate donor to catalyze the sulfonation of the hydroxyl
CC       group of hydroxysteroids and bile acids (PubMed:2754334). Prefered
CC       substrates are dehydroepiandrosterone (DHEA, also known as 3beta-
CC       hydroxyandrost-5-en-17-one) and 3beta-hydroxy-5-cholenoate, but can
CC       also catalyze deoxycholate and its conjugates, and lithocholate
CC       conjugates, in vitro (PubMed:2754334). {ECO:0000269|PubMed:2754334}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + an alcohol = adenosine 3',5'-
CC         bisphosphate + an alkyl sulfate + H(+); Xref=Rhea:RHEA:22552,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30879, ChEBI:CHEBI:58339,
CC         ChEBI:CHEBI:58343, ChEBI:CHEBI:83414; EC=2.8.2.2;
CC         Evidence={ECO:0000269|PubMed:2306259, ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22553;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + glycolithocholate = adenosine
CC         3',5'-bisphosphate + H(+) + sulfoglycolithocholate;
CC         Xref=Rhea:RHEA:10908, ChEBI:CHEBI:15378, ChEBI:CHEBI:58339,
CC         ChEBI:CHEBI:58343, ChEBI:CHEBI:60007, ChEBI:CHEBI:60008; EC=2.8.2.14;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10909;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + taurolithocholate = adenosine
CC         3',5'-bisphosphate + H(+) + taurolithocholate 3-sulfate;
CC         Xref=Rhea:RHEA:14013, ChEBI:CHEBI:15378, ChEBI:CHEBI:17179,
CC         ChEBI:CHEBI:58301, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343; EC=2.8.2.14;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14014;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3beta-hydroxyandrost-5-en-17-one
CC         = adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate +
CC         H(+); Xref=Rhea:RHEA:51216, ChEBI:CHEBI:15378, ChEBI:CHEBI:28689,
CC         ChEBI:CHEBI:57905, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343;
CC         Evidence={ECO:0000269|PubMed:2306259, ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51217;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3beta-hydroxy-5-cholenate =
CC         3beta-sulfo-5-cholenate + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:77199, ChEBI:CHEBI:15378, ChEBI:CHEBI:58339,
CC         ChEBI:CHEBI:58343, ChEBI:CHEBI:195610, ChEBI:CHEBI:195614;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77200;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + deoxycholate = 3alpha-
CC         sulfodeoxycholate + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:77203, ChEBI:CHEBI:15378, ChEBI:CHEBI:23614,
CC         ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:195622;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77204;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + glycodeoxycholate = 3alpha-
CC         sulfoglycodeoxycholate + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:77207, ChEBI:CHEBI:15378, ChEBI:CHEBI:58339,
CC         ChEBI:CHEBI:58343, ChEBI:CHEBI:82982, ChEBI:CHEBI:195624;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77208;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + taurodeoxycholate = 3alpha-
CC         sulfotaurodeoxycholate + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:77211, ChEBI:CHEBI:15378, ChEBI:CHEBI:36261,
CC         ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:195625;
CC         Evidence={ECO:0000269|PubMed:2754334};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77212;
CC         Evidence={ECO:0000305|PubMed:2754334};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=43 uM for 3'-phosphoadenylyl sulfate {ECO:0000269|PubMed:2754334};
CC         KM=0.72 uM for 3beta-hydroxyandrost-5-en-17-one (DHEA)
CC         {ECO:0000269|PubMed:2754334};
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:2754334};
CC   -!- SUBUNIT: Oligomer. {ECO:0000269|PubMed:8352748}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:2754334}.
CC   -!- TISSUE SPECIFICITY: Liver, exhibiting a sex-dependent spatial
CC       localization in the lobule of the liver. {ECO:0000269|PubMed:8352748}.
CC   -!- DEVELOPMENTAL STAGE: There is a marked sex difference (female >> male)
CC       in the cytosolic level of this protein. Its activity increases after
CC       birth in parallel in both sexes until the weanling stage. Thereafter
CC       the activity decreases in males, whereas it declines temporarily in
CC       females and increases again to a maximum level in adult females.
CC       {ECO:0000269|PubMed:8352748}.
CC   -!- INDUCTION: The ST activities display gender- and age-dependent
CC       alterations and are known to be under the regulation of gonadal,
CC       adrenal and growth hormones.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M33329; AAA42183.1; -; mRNA.
DR   EMBL; X63410; CAA45007.1; -; mRNA.
DR   EMBL; M29301; AAA42151.1; ALT_TERM; Genomic_DNA.
DR   PIR; I60190; I60190.
DR   RefSeq; NP_036827.3; NM_012695.3.
DR   AlphaFoldDB; P22789; -.
DR   SMR; P22789; -.
DR   iPTMnet; P22789; -.
DR   PhosphoSitePlus; P22789; -.
DR   GeneID; 24902; -.
DR   KEGG; rno:24902; -.
DR   UCSC; RGD:3727; rat.
DR   AGR; RGD:3727; -.
DR   CTD; 629219; -.
DR   RGD; 3727; Sult2a6.
DR   InParanoid; P22789; -.
DR   OrthoDB; 3083090at2759; -.
DR   PhylomeDB; P22789; -.
DR   TreeFam; TF321745; -.
DR   BRENDA; 2.8.2.2; 5301.
DR   Reactome; R-RNO-156584; Cytosolic sulfonation of small molecules.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   PRO; PR:P22789; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0004027; F:alcohol sulfotransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047704; F:bile-salt sulfotransferase activity; IEA:RHEA.
DR   GO; GO:0008146; F:sulfotransferase activity; IBA:GO_Central.
DR   GO; GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0051923; P:sulfation; IBA:GO_Central.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   PANTHER; PTHR11783:SF8; SULFOTRANSFERASE 2A1; 1.
DR   PANTHER; PTHR11783; SULFOTRANSFERASE SULT; 1.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; Lipid metabolism; Reference proteome;
KW   Steroid metabolism; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2113604,
FT                   ECO:0000269|PubMed:2754334, ECO:0000269|PubMed:8352748"
FT   CHAIN           2..284
FT                   /note="Sulfotransferase 2A6"
FT                   /id="PRO_0000085143"
FT   ACT_SITE        98
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         43..48
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         120
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         128
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         183
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         217..222
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   BINDING         246..248
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250|UniProtKB:Q06520"
FT   CONFLICT        18
FT                   /note="P -> S (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        24..33
FT                   /note="NVCNKFVVKE -> DVNKSVKD (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="Y -> N (in Ref. 2; CAA45007)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   284 AA;  33252 MW;  131F67150862E51D CRC64;
     MPDYTWFEGI PFPAFGIPKE TLQNVCNKFV VKEEDLILLT YPKSGTNWLI EIVCLIQTKG
     DPKWIQSVTI WDRSPWIETD LGYDMLIKKK GPRLITSHLP MHLFSKSLFS SKAKVIYLIR
     NPRDVLVSGY YFWGKTTLAK KPDSLGTYVE WFLKGYVPYG SWFEHIRAWL SMRELDNFLL
     LYYEDMKKDT MGTIKKICDF LGKKLEPDEL DLVLKYSSFQ VMKENNMSNY NLMEKELILP
     GFTFMRNGTT GDWKNHFTVA QAEAFDKVFQ EKMAGFPPGM FPWD
//
